Merck plans new product launch across Latin America for 2016
Thursday, October 01, 2015
German drug maker Merck KGaA (MKGAY) said it expects the Latin America region to keep driving growth at its Consumer Health business, as demand for consumer goods in the region is constantly rising.
Uta Kemmerich-Keil, CEO and President of Merck's Consumer Health business, outlined the business propositions to meet the needs of the local emerging middle classes, for example the consumerization of the Neurobion and Floratil brands as well as the geographic expansion of the Bion brand into Brazil.
As a solid signal of Merck's Consumer Health business commitment to the region, Kemmerich-Keil pre-announced the launch of a new innovative product across almost the entire Latin American region in 2016.
As the successful implementation of the 3x3 strategy in the region remains the focus - aiming at a minimum of 3% market share and at least 3 leading brands per market - Latin America has been showing the best performance for Consumer Health globally. The region is expected to see the majority of the business global strategic initiatives by the end of the decade.
rttnews.com
